Valhi, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US9189052098
USD
12.29
-0.78 (-5.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Valhi, Inc. stock-summary
stock-summary
Valhi, Inc.
Specialty Chemicals
Valhi, Inc. is a holding company. The Company operates through three segments: Chemicals, Component Products, and Real Estate Management and Development. The Company operates through its subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc. (Kronos) and CompX International Inc. (CompX). The Chemicals segment operates through Kronos. Kronos is a producer and marketer of titanium dioxide pigments (TiO2). The Component Products segment operates through CompX. CompX is a manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare and a range of other industries. The Real Estate Management and Development segment operates through Basic Management, Inc. (BMI) and The LandWell Company (LandWell).
Company Coordinates stock-summary
Company Details
5430 Lyndon B Johnson Fwy Ste 1700 , DALLAS TX : 75240-2620
stock-summary
Tel: 1 972 23317007 972 2331700
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 26 Schemes (2.36%)

Foreign Institutions

Held by 12 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Loretta Feehan
Non-Executive Chairman of the Board
Mr. Robert Graham
President, Chief Executive Officer, Vice Chairman of the Board
Dr. Thomas Barry
Independent Director
Ms. Terri Herrington
Independent Director
Mr. W. Hayden McIlroy
Independent Director
Ms. Mary Tidlund
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
540 Million
(Quarterly Results - Jun 2025)
Net Profit:
8 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 481 Million (Micro Cap)

stock-summary
P/E

2.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

95.04%

stock-summary
Debt Equity

0.39

stock-summary
Return on Equity

13.25%

stock-summary
Price to Book

0.45